Merlini G - Search Results

1

Long-term effects of parenteral dichloromethylene bisphosphonate (CL2MBP) on bone disease of myeloma patients treated with chemotherapy.

Merlini G, Parrinello GA, Piccinini L, Crema F, Fiorentini ML, Riccardi A, Pavesi F, Novazzi F, Silingardi V, Ascari E. Merlini G, et al. Hematol Oncol. 1990 Jan-Feb;8(1):23-30. doi: 10.1002/hon.2900080104. Hematol Oncol. 1990. PMID: 2137106

2

Multiple myeloma.

Ascari E, Merlini G, Riccardi A. Ascari E, et al. Among authors: merlini g. Ann Ital Med Int. 1990 Jul-Sep;5(3 Pt 3):312-21. Ann Ital Med Int. 1990. PMID: 2081091 Review.

3

A prospective, controlled, nonrandomized study on prophylactic parenteral dichloromethylene bisphosphonate (clodronate) in multiple-myeloma.

Riccardi A, Ucci G, Brugnatelli S, Mora O, Merlini G, Piva N, Depaoli A, Barbarano L, Distasi M, Alberio F, Nicoletti G, Morandi S, Rinaldi E, Piccinini L, Ascari E. Riccardi A, et al. Among authors: merlini g. Int J Oncol. 1994 Oct;5(4):833-9. doi: 10.3892/ijo.5.4.833. Int J Oncol. 1994. PMID: 21559649

4

Treatment of painful bone lesions and hypercalcemia.

Ascari E, Attardo-Parrinello G, Merlini G. Ascari E, et al. Among authors: merlini g. Eur J Haematol Suppl. 1989;51:135-9. doi: 10.1111/j.1600-0609.1989.tb01506.x. Eur J Haematol Suppl. 1989. PMID: 2534078

5

Effects of a new aminodiphosphonate (aminohydroxybutylidene diphosphonate) in patients with osteolytic lesions from metastases and myelomatosis. Comparison with dichloromethylene diphosphonate.

Attardo-Parrinello G, Merlini G, Pavesi F, Crema F, Fiorentini ML, Ascari E. Attardo-Parrinello G, et al. Among authors: merlini g. Arch Intern Med. 1987 Sep;147(9):1629-33. Arch Intern Med. 1987. PMID: 2957971 Clinical Trial.

6

A plea to overcome the concept of "staging" and related inadequacy in multiple myeloma.

Gobbi PG, Bertoloni D, Grignani G, Pieresca C, Rossi A, Rutigliano L, Merlini G, Riccardi A, Ascari E. Gobbi PG, et al. Among authors: merlini g. Eur J Haematol. 1991 Mar;46(3):177-81. doi: 10.1111/j.1600-0609.1991.tb01273.x. Eur J Haematol. 1991. PMID: 2009950

7

[Use of diphosphonates in the treatment of hypercalcemia in multiple myeloma: efficacy of 4-amino-hydroxybutylidene-1,1-bisphosphonate (AHButBP)].

Attardo-Parrinello G, Crema F, Merlini G, Spaghi A, Fiorentini ML. Attardo-Parrinello G, et al. Among authors: merlini g. Medicina (Firenze). 1988 Jan-Mar;8(1):75-6. Medicina (Firenze). 1988. PMID: 3226251 Italian. No abstract available.

8

Serum thymidine kinase and beta-2 microglobulin in monoclonal gammopathies.

Ucci G, Riccardi A, Luoni R, Spriano P, Merlini G, Danova M, Cassano E, Molinari E, Ascari E. Ucci G, et al. Among authors: merlini g. Tumori. 1987 Oct 31;73(5):445-9. doi: 10.1177/030089168707300503. Tumori. 1987. PMID: 3318049

9

Peptichemio, vincristine and prednisone versus melphalan and prednisone as induction therapy in multiple myeloma.

Riccardi A, Merlini G, Montecucco C, Danova M, Ucci G, Cassano E, Ascari E. Riccardi A, et al. Among authors: merlini g. Eur J Cancer Clin Oncol. 1986 Jul;22(7):787-91. doi: 10.1016/0277-5379(86)90364-0. Eur J Cancer Clin Oncol. 1986. PMID: 3770037 Clinical Trial.

10

Peptichemio, vincristine, prednisone induction treatment in multiple myeloma.

Merlini G, Riccardi A, Riccardi PG, Montecucco CM, Pavesi F, Ascari E. Merlini G, et al. Tumori. 1985 Dec 31;71(6):581-8. doi: 10.1177/030089168507100611. Tumori. 1985. PMID: 4082291

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

630 results

Search Page

Filters